PHARMCARE 5: COMPARES THE COST OF TWO OR MORE ALTERNATIVES THAT HAVE A DEMONSTRATED EQUIVALENCE IN THERAPEUTIC OUTCOME

STRAIGHTFORWARD AND SIMPLE

LEAST COST ALTERNATIVE IS CHOSEN

Question

COMPARES THE COST OF TWO OR MORE ALTERNATIVES THAT HAVE A DEMONSTRATED EQUIVALENCE IN THERAPEUTIC OUTCOME

STRAIGHTFORWARD AND SIMPLE

LEAST COST ALTERNATIVE IS CHOSEN

LEIGHTON DWIGHT OBILLOS · Accepted Answer

COST 
MINIMIZATION 
ANALYSIS (CMA)

COMPARES THE COST OF TWO OR MORE ALTERNATIVES THAT HAVE A DEMONSTRATED EQUIVALENCE IN THERAPEUTIC OUTCOME STRAIGHTFORWARD AND SIMPLE LEAST COST ALTERNATIVE IS CHOSEN